Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Blood
|
August 5, 2021
Platelets modulate T-cell activity
Ulrike Seifert, Andreas Greinacher
Biochemical Society Transactions
|
September 17, 2008
Remodelling of the ubiquitin-proteasome system in response to interferons
Ulrike Seifert, Elke Krüger
International Journal of Molecular Sciences
|
April 12, 2022
Recycling and Reshaping-E3 Ligases and DUBs in the Initiation of T Cell Receptor-Mediated Signaling and Response
Clemens Cammann, Nicole Israel, Hortense Slevogt, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 4, 2020
Structure and function of the ubiquitin-proteasome system in platelets
Lisa Colberg, Clemens Cammann, Andreas Greinacher, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 3, 2012
Emerging roles of immunoproteasomes beyond MHC class I antigen processing
Frédéric Ebstein, Peter-Michael Kloetzel, Elke Krüger, et al.
Transfusion
|
July 31, 2021
The platelet proteasome and immunoproteasome are stable in buffy-coat derived platelet concentrates for up to 7 days
Lisa Colberg, Clemens Cammann, Jan Wesche, et al.
The International Journal of Biochemistry & Cell Biology
|
November 26, 2008
Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system
Frédéric Ebstein, Nicole Lange, Sabrina Urban, et al.
Immunological Reviews
|
September 27, 2005
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing
Britta Strehl, Ulrike Seifert, Elke Krüger, et al.
Frontiers in Cellular and Infection Microbiology
|
March 14, 2022
<i>Streptococcus pneumoniae</i> and Influenza A Virus Co-Infection Induces Altered Polyubiquitination in A549 Cells
Thomas Sura, Vanessa Gering, Clemens Cammann, et al.
European Journal of Microbiology & Immunology
|
October 17, 2017
Low Neurotoxicity of ONX-0914 Supports the Idea of Specific Immunoproteasome Inhibition as a Side-Effect-Limiting, Therapeutic Strategy
Laura von Brzezinski, Paula Säring, Peter Landgraf, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Blood
|
August 5, 2021
Platelets modulate T-cell activity
Ulrike Seifert, Andreas Greinacher
Biochemical Society Transactions
|
September 17, 2008
Remodelling of the ubiquitin-proteasome system in response to interferons
Ulrike Seifert, Elke Krüger
International Journal of Molecular Sciences
|
April 12, 2022
Recycling and Reshaping-E3 Ligases and DUBs in the Initiation of T Cell Receptor-Mediated Signaling and Response
Clemens Cammann, Nicole Israel, Hortense Slevogt, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 4, 2020
Structure and function of the ubiquitin-proteasome system in platelets
Lisa Colberg, Clemens Cammann, Andreas Greinacher, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 3, 2012
Emerging roles of immunoproteasomes beyond MHC class I antigen processing
Frédéric Ebstein, Peter-Michael Kloetzel, Elke Krüger, et al.
Transfusion
|
July 31, 2021
The platelet proteasome and immunoproteasome are stable in buffy-coat derived platelet concentrates for up to 7 days
Lisa Colberg, Clemens Cammann, Jan Wesche, et al.
The International Journal of Biochemistry & Cell Biology
|
November 26, 2008
Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system
Frédéric Ebstein, Nicole Lange, Sabrina Urban, et al.
Immunological Reviews
|
September 27, 2005
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing
Britta Strehl, Ulrike Seifert, Elke Krüger, et al.
Frontiers in Cellular and Infection Microbiology
|
March 14, 2022
<i>Streptococcus pneumoniae</i> and Influenza A Virus Co-Infection Induces Altered Polyubiquitination in A549 Cells
Thomas Sura, Vanessa Gering, Clemens Cammann, et al.
European Journal of Microbiology & Immunology
|
October 17, 2017
Low Neurotoxicity of ONX-0914 Supports the Idea of Specific Immunoproteasome Inhibition as a Side-Effect-Limiting, Therapeutic Strategy
Laura von Brzezinski, Paula Säring, Peter Landgraf, et al.
Page
of 6